Friday, 2nd May 2025
Articles
― Friday, 12th June 2020
Availing Patent Benefits – A ‘Status’ Check! Every patent office provides certain benefits to Patent Applicants if they meet certain criteria (with respect to entity size, gross income and others). These benefits may be patent fee discounts or speedy examination processes. This article touches upon the benefits extended by IPO, USPTO and EPO to entities based on their status. -IPproTeam #Patent101, #Patent Office, #Indian Patent Office, #IPO, #USPTO, #Patent Filing, #Filing, #Invention, #Start-up #Startup, #Entrepreneur, #MSME, #SMEs, #Micro Entity, #Small Entity, #Non-Profit, #University, #Public Research, #DPIIT
― Wednesday, 27th May 2020
Not an Equal world for AI - No Inventorship for them! With Artificial intelligence (AI) replacing humans in myriad sectors and operational aspects, it is not surprising that AI is able to concoct its own inventions. AI-generated inventions are (and may become) the norm, however, awarding inventorship to AI under the current patent system is far-fetched. So, is it justifiable denying patent rights to the actual inventor for inventions created by AI or does the patent system merely operate on the fact that AI is a machine with no capability to exercise legal rights even if given any, and therefore unfit to hold inventorship for its creations. -Authors: Nethravathi D | Abhijith Paipad #AI as Inventor, #AI, #Artificial Intelligence, #Invention, #Inventorship, #AI Creations, #IPO, #Indian Patent Office, #USPTO, #EPO, #CNPO, #KIPO, #JPO, #Patent Rights
― Wednesday, 27th May 2020
First Filing in India: A Requirement or a Choice? Indian resident inventors may decide to file patent applications in multiple countries including India or entirely disregard India and go international! This may be due to weak market strength/poor demand for the product/invention in the country. As per Indian Patents Act, it is mandatory to obtain an Foreign Filing License (FFL) if an Indian resident inventor decides to first file in a foreign country bypassing Indian Patent Office(IPO) . As per the rules, within 21 days of requesting for an FFL, the IPO, usually, either issues the FFL certificate or rejects the FFL request. Another option is to first file in India and then wait for a cooling-off period (six weeks!) before attempting to file in a foreign country. In this case, an FFL is not required. -IPproTeam #Patent101, #FFL, #First Filing, #Patent Office, #Foreign Filing License, #Indian Patent Office, #IPO, #Indian Resident, # Patent Filing, #Filing, #Invention, #Technology, #Secrecy Provision
― Friday, 22nd May 2020
The Missing Link - IT Act and IPR Laws Cyber laws are defined under the Information Technology (IT) Act of 2000 encompassing legal and regulatory aspects of the internet and the world wide web. However, certain entities/intermediaries such as e-commerce websites, search engines, and data aggregators sometimes come under scrutiny for violation of IPR laws when seen under the light of IT Act. Hence, protection to intermediaries from liability, arising out of content posted by users, needs be addressed by creating nexus between IT Act and IPR laws. -Author: Abhijith Paipad #Informationtechnology, #copyright, #Trademark, #infringment, #IPR, #ITact, #DMCA, #intermediary, #intellectualproperty, #cyberlaw
― Wednesday, 20th May 2020
Keeping an Eye on India - USA’s IP Priority Watch List India has been grappling with big IP giants such as the US to establish its stance on the IP front. Owing to a fallible IP regime, India has yet again come under the US’s Priority Watch List and is required to meet certain expectations of the US in terms of trade and other IPR related policies. However, the question still remains whether India, being a sovereign nation, should let itself be subdued by the US or have its own say in IP matters concerning the nation. -Author: Emily Premkumar #IPwatchlist, #Prioritywatchlist, #USA, #India, #IndiaPatentOffice, #IPO, #Patent, #PatentFiling, #PatentEnforcement, #CompulsoryLicensing
LOAD MORE
|
Friday, 2nd May 2025
IP Speak
― Friday, 2nd May 2025
The Application of Generic Machine Learning to New Data Environments Requires “Something More” to be Patent Eligible READ MORE
― Friday, 2nd May 2025
The Surge of Gulf of America Trademarks: A Unique Legal Landscape of Opportunities and Hurdles READ MORE
― Wednesday, 30th April 2025
First impressions: Federal Circuit finds applied AI claims ineligible for patenting under 35 USC 101 READ MORE
― Wednesday, 30th April 2025
US faults India on weak intellectual property protection; domestic R&D spend remains low READ MORE
LOAD MORE
|
Friday, 2nd May 2025
Current News
― Friday, 2nd May 2025
James Cropper sells IP assets for €1.75 million James Cropper plc (AIM:CRPR),
a company specializing in Advanced Materials and Paper & Packaging (NYSE:PKG), has announced
the sale of certain non-core intellectual property (IP) assets for €1.75
million in cash.
READ MORE
― Friday, 2nd May 2025
Meta faces a lawsuit from US authors over use of material from shadow library LibGen The case, which has been brought by about a
dozen authors including Ta-Nehisi Coates and Richard Kadrey, is centered around
the $1.4tn social media giant’s use of LibGen, a so-called shadow library of
millions of books, academic articles and comics, to train its Llama AI models.
READ MORE
― Friday, 2nd May 2025
Boehringer Ingelheim Pharms. Inc. v. Apotex Inc. Boehringer Ingelheim (BI)
alleged that Apotex’s submission of its linagliptin ANDA constituted
infringement of the patents-in-suit.
READ MORE
― Wednesday, 30th April 2025
Silo Pharma Expands Intellectual Property Portfolio with Patent Application for Exclusively Licensed Alzheimer’s Drug Silo
Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage
biopharmaceutical company focused on novel therapeutics and drug delivery
systems, today announced the filing of a patent application with the U.S.
Patent and Trademark Office (USPTO) focused on the neurology drug SPC-14, an
intranasal compound for the treatment of Alzheimer’s disease (AD) exclusively
licensed to Silo Pharma from Columbia University.
READ MORE
― Wednesday, 30th April 2025
U.S. Patent and Trademark Office Invalidates Pharmacyclics Patent Asserted Against BeiGene BeiGene, today announced that
the U.S. Patent and Trademark Office (USPTO) rendered a Final Written
Decision invalidating all claims of Pharmacyclics LLC’s
(Pharmacyclics) U.S. Patent No. 11,672,803 (the ‘803 patent) that
were challenged by BeiGene in a post-grant review (PGR) proceeding.
READ MORE
LOAD MORE
|
Friday, 2nd May 2025
Patent Office Update
― Wednesday, 30th April 2025
CNIPA, Intellectual Property Agency of the Republic of Azerbaijan Sign Memorandum of Understanding READ MORE
― Tuesday, 29th April 2025
Role of USPTO’s Delegated Rehearing Panel Changing With New Administration READ MORE
― Tuesday, 29th April 2025
Role of USPTO’s Delegated Rehearing Panel Changing With New Administration READ MORE
LOAD MORE
|
Site map | Follow us | Offices | ||||||||||||||||||
|
|
Bangalore | Silicon Valley | |||||||||||||||||
Who are we | 102, Prestige Loka, 7/1, Brunton Road, Bangalore- 560 025, INDIA. |
220 California Ave, Suite 201, Palo Alto, CA- 94306, USA. |
||||||||||||||||||
What we do | ||||||||||||||||||||
Industry Expertise | ||||||||||||||||||||
+91 80 6693 5000 | +1 650 325 7100 | |||||||||||||||||||
Services | ||||||||||||||||||||
Patent Drafting & Filing | Patent Prosecution | Patent Analytics & IP Strategy | IP Awareness Initiatives | Get in touch |
Mumbai | Singapore | ||||||||||||||
Prior Art Search | Patent Prosecution | Patent Invalidation Search | Workshops & Seminars | |||||||||||||||||
Patent Drafting Services | Patent Litigation Support | Freedom-To-Operate Analysis | Daily bulletin | ENQUIRE |
93-B Mittal Court, Nariman Point, Mumbai- 400 021, INDIA. |
Level 30, Six Battery Road, Singapore- 049909. |
||||||||||||||
Patent Filing Services | Landscape Analysis | Research Articles | ||||||||||||||||||
State of the art Search | ||||||||||||||||||||
IP Watch | ||||||||||||||||||||
IP Due Diligence | +91 22 6669 5000 | +65 6550 9855 | ||||||||||||||||||
Copyrights © 2016 IPpro Services (India) LLP. All rights reserved. |